Background information. In many cell lines, such as HeLa cells, STxB (Shiga toxin B-subunit) is transported from the plasma membrane to the ER (endoplasmic reticulum), via early/recycling endosomes and the Golgi apparatus, bypassing the late endocytic pathway. In human monocyte-derived macrophages and dendritic cells that are not sensitive to Shiga toxin-induced protein biosynthesis inhibition, STxB is not detectably targeted to the retrograde route and is degraded in late endosomes/lysosomes.
Introduction
Shiga toxin is a bacterial protein produced by Shigella dysenteriae, composed of two non-covalently linked subunits, A and B (O'Brien et al., 1992) . The highly related verotoxins (or Shiga-like toxins) are associated with pathological manifestations leading to haemolytic and uremic syndrome, one of the major causes of paediatric kidney failure (Lingwood, 1996; Arbus, 1997) . The monomeric A-subunit carries an RNA Nglycanase activity responsible for inhibiting protein biosynthesis, whereas the homopentameric B-subunit STxB (Shiga toxin B-subunit) allows the binding of the holotoxin to its cellular receptor, the glycosphingolipid Gb 3 (globotriaosyl ceramide) Smith et al., 2004) . In many cell lines, Shiga toxin or STxB alone follows the retrograde transport pathway from the plasma membrane to the ER (endoplasmic reticulum), via early/recycling endosomes and the Golgi apparatus, bypassing the late endocytic pathway (Mallard et al., 1998 ; for a review, see Johannes and Goud, 1998) .
The molecular mechanisms underlying retrograde transport are starting to be unravelled, in particular at the level of the interface between early/recycling endosomes and the TGN (trans-Golgi network). Indeed, it has been shown that retrograde sorting at this interface involves the small GTPase Rab6a (Mallard et al., 2002) , SNARE complexes around the heavy chain tSNAREs syntaxin 16 (Mallard et al., 2002) and syntaxin 5 (Tai et al., 2004) , clathrin Saint-Pol et al., 2004) , the phosphatidylinositol binding clathrin adaptor epsinR
Figure 1 Co-immunoprecipitation experiment (A) STxB was internalized (+) or not (−) into macrophages (left panels) or HeLa cells (right panels) for 4 h at 37
• C (Ctrl). For
HeLa cells, STxB has also been internalized at 19
• C, at 37
• C for short times (10 min), or at 37
• C after BFA-pretreatment, as indicated. The cells were then lysed in Triton X-100-containing buffer A, and anti-STxB monoclonal antibody 13C4 was added for immunoprecipitation. For macrophages, immunoprecipitation was performed on the Triton X-100-soluble (cytoplasmic) and -insoluble (nuclear) fractions. Immunoprecipitates were loaded on to Tris/Tricine gels, which were silver stained. Heavy and light chains of 13C4 are marked by circles and squares respectively. Asterisks mark co-immunoprecipitated B23 in cytoplasmic and nuclear fractions of macrophages. (B) Western-blot analysis with anti-BiP antibody of STxB immunoprecipitates obtained on HeLa cell or macrophages (Macros) into which STxB was internalized at 19 or 37
• C. The arrow indicates BiP.
( Saint-Pol et al., 2004) , and association with detergent-resistant membranes (Falguières et al., 2001; Kovbasnjuk et al., 2001) . The retrograde route is also used by cellular proteins such as TGN38/46 (Ghosh et al., 1998; Mallard et al., 1998 Mallard et al., , 2002 and the mannose 6-phosphate receptors (see Saint-Pol et al., 2004; and references therein) . In contrast with HeLa cells, it has been shown that monocytes and macrophages are resistant to the inhibition of protein biosynthesis induced by Shiga toxin, despite the expression of the Shiga toxin receptor Gb 3 (Tesh et al., 1994; Ramegowda and Tesh, 1996; van Setten et al., 1996) . This resistance was paralleled by our observations that as opposed to HeLa cells, Shiga toxin is not detergent resistant membrane associated in human monocytes and monocytederived macrophages and dendritic cells and does not detectably use the retrograde route in these cells (Falguières et al., 2001) . Surprisingly, antigen presentation experiments showed that STxB can introduce exogenous antigenic peptides and proteins into the MHC class I-restricted antigen presentation pathway of human and mouse dendritic cells (Lee et al., 1998; Haicheur et al., 2000 Haicheur et al., , 2003 , requiring cytosolic processing (Haicheur et al., 2000) . Whether translocation to the cytosol involves low-level trafficking via the retrograde route and retrotranslocation at the ER, or endosomal membrane translocation remains an open question.
In the present study, we have compared proteins that interact with STxB in HeLa cells and human monocyte-derived macrophages. Consistent with the transport differences that allow retrograde STxB trafficking to the ER in HeLa cells, but not in macrophages, we found that STxB interacted with the ER chaperone BiP (binding protein) exclusively in HeLa cells. STxB also interacted with the nucleolar protein B23. Evidence is presented that at least in macrophages, STxB may localize to nucleoli in a process that appears to require ATP for translocation to the cytosol, but not for nuclear import.
Results

Interaction of STxB with the ER chaperone BiP in HeLa cells
Shiga toxin is targeted to the ER in toxin-sensitive HeLa cells, but not in toxin-resistant macrophages (Falguières et al., 2001) . To further investigate this difference, we isolated STxB binding proteins. STxB was internalized into macrophages and HeLa cells, and then immunoprecipitated (Figure 1) . One of the interacting proteins was specific to HeLa cells, and sequencing identified this protein as the ER-resident chaperone BiP. The interaction with BiP was only observed under conditions that allowed STxB access to the ER: if STxB was internalized into HeLa cells at low temperatures (Figure 1A, right panel, 19.5 • C; Figure 1B ), for short times ( Figure 1A , right panel, 10 min), or in the presence of BFA (brefeldin A; Figure 1A , right panel) that totally blocks retrograde transport (Mallard et al., 1998) , no BiP was found in the immunoprecipitate. These results strongly suggest that in HeLa cells, BiP and STxB are found in the same complex once the latter has reached ER by retrograde transport. No STxB-BiP complex was detected in macrophages ( Figure 1A , left panel), even after Western-blot analysis of the interacting proteins ( Figure 1B) . Quantification of these gels showed that one STxB pentamer interacted with one BiP protein.
Interaction of STxB with the nucleolar protein B23 both in HeLa cells and macrophages
Another STxB interacting protein that was found by co-immunoprecipitation in both cell types was identified as the nucleolar protein B23 ( Figure 1A) , also termed numatrin, nucleoplasmin or NO38. On high-resolution gels, the protein migrated as a doublet, and microsequencing of both bands confirmed that they corresponded to the B23.1 and B23.2 isoforms (Chang and Olson, 1989; Zhang et al., 1989) . The STxB-B23 complex was found in macrophages after co-immunoprecipitation with Triton X-100-soluble or nuclear material ( Figure 1A , left panel). The quantities of co-immunoprecipitated B23 were quite different between macrophages and HeLa cells, reflecting that much less STxB is internalized into macrophages (compare the intensities of the STxB bands in HeLa cells and macrophages). This reflects that macrophages express approx. 20-fold less Gb 3 than HeLa cells (Falguières et al., 2001) . However, the stoichiometry of the STxB-B23 interaction was estimated at one B23 protein per STxB monomer for both cells types. This STxB-B23 stoichiometry was the same for all HeLa cell conditions shown in Figure 1 , with the exception of the control in which no STxB was internalized (see Supplementary Table S1 at http://www.biolcell. org/boc/098/boc0980125add.htm).
STxB association with nucleoli
Our previous study had allowed us to detect STxB accumulation in a subnuclear compartment in macrophages (Falguières et al., 2001 ). Using double labelling, we could show that these structures corresponded to B23-positive nucleoli (Figure 2A, upper panel) . For specificity controls, we found similar results on methanol-fixed cells (note that B23 labelling was partially affected under these conditions), and observed that nucleolar labelling was not detected when STxB was incubated with macrophages on ice or with fixed cells (results not shown). Nucleolar accumulation was more pronounced with STxB-Glyc-KDEL fusion protein (see Johannes et al., 1997) compared with wild-type STxB, and the former protein was used for the remainder of the work described in this paper.
To confirm these morphological observations by biochemical means, iodinated STxB-Glyc-KDEL was internalized into macrophages, which were then lysed in a Triton X-100-containing buffer. Triton X-100 soluble and insoluble materials were separated by centrifugation followed by STxB immunoprecipitation and gel analysis ( Figure 2B ). Morphological analysis confirmed that upon extraction with the detergent (Figure 2A , lower panel, TX-100), the cytoplasmic STxB labelling (red) disappeared completely, while the discrete nucleolar STxB labelling, in co-localization with B23 (green), persisted under these conditions. Thus it could be assumed that Triton X-100-insoluble material from biochemical fractionation ( Figure 2B ) corresponded to nuclear STxB-Glyc-KDEL. The latter was mostly composed of non-cleaved proteins and two minor proteolytic cleavage products (crosses in Figure 2B ). In contrast, detergent-soluble STxB-Glyc-KDEL was composed of non-cleaved proteins and a previously described cleavage product (open circle in Figure 2B ; Johannes et al., 1997) . Importantly, the cleavage products were not the same in the nuclear and the Triton X-100-soluble fractions, indicating that nuclear STxB localization did not result from protein relocalization during lysis. This was further confirmed by the following two experiments. First, when a chase period preceded lysis, STxB-Glyc-KDEL recovered from the Triton X-100-soluble fraction was transformed into the cleavage product, whereas for the nuclear fraction, the ratio between non-cleaved STxB-Glyc-KDEL and the cleavage products changed only slightly ( Figure 2B ). Secondly, in presence of a 10 4 -fold molar excess of non-radioactive competitor STxB protein during macrophage lysis, the amount of • C. The cells were then put on ice and either fixed directly (control) or preextracted for 1 min with 1% Triton X-100 solution before fixation (TX-100). The cells were then stained for STxB (left panels, red) and B23 (right panels, green). Note that STxB was readily extracted from cytoplasmic (endosomal) structures when cells were preextracted with Triton X-100, but remained associated with nucleoli, in parallel with B23. (B) Iodinated STxB-Glyc-KDEL (50 nM) was internalized for 4 h at 37
• C into macrophages. The cells were then put on ice, washed and lysed directly in 1% Triton X-100 buffer in the presence (+) or absence (−) of a 10 4 -fold excess of non-radioactive competitor protein, or chased for 2 h at 37
• C before lysis in the absence of the competitor protein. Triton X-100-insoluble material (nuclear fraction) was removed by centrifugation, and STxB in the nuclear and the Triton X-100-soluble fractions was immunoprecipitated with anti-STxB 13C4 antibody and analysed by gel electrophoresis. Note that the presence of the competitor protein did not decrease STxB associated with the nuclear fraction, and that the proteolytic profiles were different in the nuclear (×) and the Triton X-100-soluble (᭺) fractions indicating that STxB association with the nuclear fraction did not result from protein relocalization during lysis. The cells were lysed in a buffer containing non-radioactive ('Cold') STxB at the indicated molar excess, and the association of [ 125 I]STxB-Glyc-KDEL with Triton X-100-insoluble material (nuclear, see Figure 2B ) was expressed as the percentage of total cell-associated radioactivity. Means (+ − S.E.M.) of two (binding) radiolabelled STxB-Glyc-KDEL in the nuclear fraction was not altered ( Figure 2B ). This is in contrast with HeLa cells in which under similar conditions the presence of non-radioactive competitor protein during lysis leads to a dose-dependent decrease in Triton X-100 (nuclear) [ 125 I]STxB-Glyc-KDEL (Figure 3, internalization) . At 10 4 -fold molar excess of non-radioactive competitor STxB protein, nuclear radiolabelled STxB was more than 2-fold reduced. Strikingly, when [
125 I]STxB-Glyc-KDEL was only bound to the plasma membrane by incubation with HeLa cells on ice, a large fraction was recovered on nuclei after lysis (Figure 3, binding) . This was due to post-lysis relocalization because non-radioactive competitor protein totally prevented the appearance of Triton X-100-insoluble counts.
In summary, these experiments suggest that after internalization, a fraction of STxB was already Figure 4 STxB association with nucleoli also occurs at low temperatures (A, B) STxB (0.1 µM) was internalized for 30 min into macrophages at 18
• C (A), or at 37
• C (B). Cells were then fixed and stained for STxB (left panels, red) and B23 (middle panels, green). Merging of both channels is shown on the right panels. Arrows on the left panels indicate STxB co-localization with B23. Note that even after internalization at 18
• C, STxB could be detected on nucleoli.
associated with nuclei before the cells were lysed, at least in macrophages.
Requirements for nucleolar accumulation
It was described previously that retrograde targeting to the biosynthetic-secretory pathway is inhibited under low temperature incubation conditions (Mallard et al., 1998) . In the present study, we observed that nucleolar accumulation on macrophages occurred at 18
• C ( Figure 4A ) as efficiently as under control conditions at 37
• C ( Figure 4B ), indicating that STxB accumulation on nucleoli does not depend on trafficking via the biosynthetic-secretory pathway. This was further confirmed by the observation that STxB accumulation in nucleoli was not inhibited by BFA (results not shown), which is known to induce the redistribution of Golgi markers into the ER leading to a complete blockage of anterograde (Lippincott-Schwartz et al., 1989) and retrograde transport (Mallard et al., 1998) . STxB accumulation in nucleoli was not inhibited by drugs such as bafilomycin, chloroquine and ammonium chloride that would increase endosomal pH.
To define the ATP-dependence of STxB accumulation on nucleoli, an ATP-depletion system was added at various times after the beginning of a 30 min STxB internalization pulse on macrophages. The cells were then fixed and double stained for STxB ( Figure 5A , upper panel) or B23 ( Figure 5A, lower panel) . When the depletion system was initially added together with STxB ( Figure 5A , 0 min), STxB was found in vesicular cytoplasmic structures, co-localizing with 3 kDa dextran (Falguières et al., 2001 ), but not in nucleoli. When the ATP-depletion system was added after 10 min of STxB internalization, weak nucleolar staining of STxB became apparent, in addition to the cytoplasmic staining ( Figure 5A , 10 min). Nucleolar staining further increased when the depletion system was added after 20 min, compared with control cells where the depletion system was added directly before fixation ( Figure 5A , 30 min). The ratio of STxB to B23-specific labelling in nucleoli was determined using quantitative image analysis methods (see the Materials and methods section). This quantification confirmed that STxB was less abundant in nucleoli when the ATP-depletion system was added early (Figure 5B, ᭺) . Importantly, even though total STxB labelling (cytoplasmic and nucleolar signals; Figure 5B , ) was lower in the presence of the ATP-depletion system due to inhibition of endocytosis, it had less effect compared with nucleolar STxB labelling. Similar results were obtained when STxB access to the nucleus was sampled biochemically (Triton X-100 insolubility; Figure 5C ). We found that the percentage of nuclear STxB increased the latter when the ATPdepletion system was added ( Figure 5C ). The data presented in Figure 6 show that STxB, when added to SLO (streptolysin-O)-permeabilized cells, can diffuse passively into the nucleus, i.e. in the absence of cytosol and ATP. In summary, these experiments allowed us to uncouple an early ATP-dependent step in STxB traffic in macrophages -endocytosis -from a later ATP-dependent step, possibly by trafficking to a membrane translocation competent compartment and/or to a membrane translocation itself.
The kinetics of an STxB association with nucleoli was assessed by morphological and biochemical means ( Figure 5D ). STxB was internalized into macrophages for the indicated times after which the cells were fixed. The ratio of STxB-to B23-specific labelling was determined as described above. After short incubations, minimal STxB-specific labelling • C for 30 min into macrophages. An ATP-depletion system was added from the beginning of the internalization pulse (0 min), or after 10, 20 or 30 min of internalization. The cells were then fixed, and stained for STxB and B23. The STxB staining in nucleoli was weak when the ATP-depletion system was added early. (B) Experiments as described in (A) were analysed using image quantification methods. The total cellular labelling (total labelling, ) and the ratio of fluorescence intensities in nucleoli of STxB and B23 (B/B23, ᭺) were determined for a total of at least 150 cells of three independent experiments (means + − S.E.M.). (C) Iodinated STxB-Glyc-KDEL (50 nM) was internalized for 30 min at 37
• C into macrophages. The ATP-depletion system was added as described in (A). After the internalization pulse, the cells were put on ice and, Triton X-100-insoluble (nuclear) and -soluble materials were separated as described in Figure 2 (B). Means (+ − S.E.M.) of three independent experiments performed in duplicate are shown. The later the ATP-depletion system was added the more the fraction of nuclear STxB increased. (D) Analysis of the kinetics of STxB association with nucleoli. Unlabelled (᭺) or iodinated () STxB-Glyc-KDEL were internalized for the indicated times at 37
• C into macrophages. The cells were then either fixed and analysed by immunofluorescence, as described in (A) and (B), or put on ice and analysed as described in (C). Note that STxB association with nucleoli has reached its plateau value after 2 h.
was detected in nucleoli, whereas a gradual increase in nucleolar labelling was observed during longer incubations ( Figure 5D , ᭺). Half maximal accumulation was observed after approx. 30 min. Similar results were obtained when nuclear accumulation was detected biochemically using Triton X-100 fractionation ( Figure 5D , ).
Discussion
In toxin-sensitive cells, STxB naturally transports the catalytic A-subunit to an intracellular site from which the latter is translocated to the cytosol. It is commonly assumed that for protein toxins with similar intracellular itineraries such as Shiga toxin, this compartment is the ER (Simpson et al., 1999; Wesche et al., 1999; Tsai et al., 2001 ). In agreement with this hypothesis, we describe here that STxB interacts with BiP, an ER-localized molecular chaperone that has been implicated in the retrotranslocation process to the cytosol (Plemper et al., 1997) . This finding parallels our previously described observation of co-localization between STxB and BiP in HeLa cells (Falguières et al., 2001 ). Whether and how BiP intervenes in Shiga toxin retrotranslocation remains to be determined. BiP could mask the A-subunitbinding site on STxB, favouring subunit dissociation. Alternatively, small quantities of STxB might be translocated to the cytosol as previous suggested (Nakagawa et al., 1999) . Discriminating between these possibilities will be the subject of future work. The second STxB-interacting protein that we identified in the present study is B23, an abundant, multifunctional nucleolar phosphoprotein whose activity is proposed to play a role in ribosome assembly (Borer et al., 1989) . Considering that Shiga toxin modifies rRNA, interaction with B23 might allow localization of the toxin at the site of production and assembly of its molecular target. However, several lines of evidence suggest that in toxin-sensitive cells, such as HeLa cells, a significant fraction of STxB binds B23 after fixation or lysis: (i) when bound to the plasma membrane of HeLa cells on ice, subsequent fixation with paraformaldehyde leads to the nucleolar appearance of STxB; and (ii) the presence of non-radioactive competitor protein during Triton X-100 lysis diminishes STxB localization to HeLa cell nucleoli. However, these observations do not exclude the possibility that small amounts of STxB naturally translocate to the cytosol, sufficient to bring the holotoxin to nucleoli.
When applied to human monocyte-derived macrophages, the same controls as mentioned above argue in favour of a specific interaction of STxB with B23: (i) STxB does not bind to nucleoli when added to fixed cells; (ii) the presence of a non-radioactive competitor protein during Triton X-100 lysis does not diminish STxB localization to macrophage nuclei; and (iii) after detergent lysis and fractionation, nuclear STxB does not have the same composition as cytoplasmic STxB. We have been unable to demonstrate STxB localization to nucleoli on living cells, though. This is likely explained by the fluorophore modification required for these studies, which affects nucleolar STxB localization on intact cells. The relevance of STxB-B23 interaction in macrophages is obscured by the observed resistance of these cells to Shiga toxin (Tesh et al., 1994; Ramegowda and Tesh, 1996; van Setten et al., 1996; see Supplementary Figure S1 at http://www.biolcell.org/ boc/098/boc0980125add.htm). However, we have previously reported that STxB, fused to a model tumour epitope, can induce MHC class I-restricted presentation of the antigenic peptide on monocytederived human dendritic cells (Lee et al., 1998) . On mouse D1 dendritic cells, STxB-dependent MHC class I-restricted antigen presentation was found to be proteasome-and TAP (transporter-associated with antigen presentation)-dependent (Haicheur et al., 2000) , strongly suggesting that STxB indeed delivers attached antigens to the cytosol.
The mechanism of putative STxB translocation to the cytosol in macrophages and dendritic cells remains to be established. Our results suggest that one can uncouple the ATP dependence of endocytosis from a later ATP-dependent step. This later step is most likely not nuclear import, since we observed that on SLO permeabilized cells, STxB can diffuse into the nucleus and bind to B23, even at 4
• C and in the absence of cytosol and ATP. The second ATP-dependent step could be trafficking of STxB to a membrane translocation competent compartment. As mentioned above, our previous results showed that STxB targeting into the retrograde route could not be detected in human monocyte-derived cells (Falguières et al., 2001) , making it unlikely that ER is the membrane translocation competent compartment in these cells. This conclusion is also consistent with our findings that nucleolar accumulation is not prevented by BFA and by low-temperature incubations (18
• C), both of which prevent retrograde transport to the ER (Mallard et al., 1998) . Thus membrane translocation probably occurs in the endocytic pathway. Finally, membrane translocation as such could be ATP-dependent. A role for ATPases of the ABC (ATP-binding-cassette)-transporter family with flippase activity on glycospingolipids (van Helvoort et al., 1996) is one of several possibilities. Indeed, it has been reported that the ABCtransporter MDR1 sensitizes cells for Shiga toxin (Lala et al., 2000) , the likely explanation being increased Gb 3 synthesis, however.
STxB-dependent targeting of antigens to cytosolic proteasomes of antigen presenting cells appears to be different from other cross-presentation mechanisms. First, as opposed to processes that depend on the recently described ER-phagosome system (Guermonprez et al., 2003; Houde et al., 2003) that are specific for dendritic cells, we found that STxB can also induce class I-restricted antigen presentation in B-lymphocytes (Lee et al., 1998) . Secondly, phagocytosis does not appear to be the major entry route for STxB (Falguières et al., 2001 ).
In conclusion, the targeting of antigen presenting cells and its apparent membrane translocation capacity make STxB an interesting tool for the development of immunotherapeutic approaches for the treatment of cancer and infectious diseases. Further investigations will be necessary to establish the mechanisms by which STxB appears to be capable of crossing membranes into the cytosol.
Materials and methods
Cells, antibodies and other reagents
Human monocytes were obtained, cultured and differentiated into macrophages, as described in Falguières et al. (2001) . HeLa cells were cultured in 10% (v/v) fetal calf serum containing Dulbecco's modified Eagle's medium as described in Johannes et al. (1997) . STxB, STxB-Glyc-KDEL and the monoclonal anti-STxB antibody 13C4 were obtained as previously described (Johannes et al., 1997) . Polyclonal anti-B23 and anti-BiP antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
Immunofluorescence methods
Immunofluorescence was performed as previously described (Falguières et al., 2001) . Briefly, cells were fixed at room temperature (22
• C) for 10 min in 3% (w/v) paraformaldehyde, quenched with 50 mM ammonium chloride and permeabilized with 0.05% saponin. ATP depletion was performed by adding 10 mM 2-deoxy-glucose (Sigma) and 30 mM sodium azide to cells. In some experiments, cells were extracted for 1 min on ice in 1% Triton X-100/Pipes buffer (80 mM Pipes, pH 6.8, 5 mM EGTA and 1 mM MgCl 2 ) before fixation and immunofluorescence. When indicated, HeLa cells were incubated with 4 µg/ml SLO for 10 min at 4
• C. After washing, the cells were permeabilized at 37
• C for 20 min, incubated with 1 µM Cy3-labelled STxB for 30 min at 4
• C or 37
• C in the absence of exogenous cytosol and ATP, fixed with paraformaldehyde and mounted for immunofluorescence analysis.
To quantify the mean fluorescence intensity ratio of STxB staining over B23 staining, digital images were obtained by confocal microscopy on fixed cells using a TCS4D microscope (Leica, Lasertechnik, Heidelberg, Germany). Photodetector sensitivity and laser power were adjusted on the strongest labelled preparations to avoid saturation and kept constant throughout individual experiments. STxB and B23 images were then superimposed using NIH (National Institutes of Health) image software (NIH, Bethesda, MD, U.S.A.), nucleoli were delineated on the B23 image, and mean fluorescence intensity was determined on both images. Total cellular immunofluorescence of the analysed cells was measured concurrently.
Biochemistry and co-immunoprecipitation
Trichloroacetic acid precipitation experiments, STxB-Glyc-KDEL iodination to specific radioactivity of 5000 c.p.m./ng, and glycosylation analysis were performed as described before (Johannes et al., 1997) . To assess STxB translocation to the nucleus by biochemical means, iodinated STxB-Glyc-KDEL was internalized as indicated, the cells were put on ice, 1-10 000-fold molar excess of unlabelled competitor protein in PBS was added or not added and extraction was performed for 30 min at 4
• C in 1% Triton X-100/Pipes buffer. The buffer was removed, the remaining cellular material was lysed in 0.1 M KOH, and buffer and cell lysates were counted independently. In the ATP-depletion experiment, the background of nuclear labelling obtained on cells preincubated for 30 min with the depletion system was subtracted.
For co-immunoprecipitation, STxB was internalized or not for 10 min or 4 h at 19.5
• C after prebinding into HeLa cells or continuously into macrophages. When indicated, HeLa cells were pretreated for 5 min with 5 µg/ml BFA, followed by the continuous presence of the drug during incubation with STxB. The cells were then put on ice, lysed for 10 min in buffer A (1% Triton X-100, 50 mM Hepes, pH 7.5, 150 mM NaCl, 10%, v/v, glycerol, 5 mM EDTA and protease inhibitor cocktail) and Triton X-100-insoluble material was removed by centrifugation for 10 min at 10 000 g and 4
• C. The supernatant was taken off, anti-STxB monoclonal antibody 13C4 and Protein G-Sepharose were added, and the samples were incubated for 90 min at 4
• C by end-over-end rotation. Beads were then collected by centrifugation, washed three times with buffer A, resuspended in sample buffer (150 mM Tris/HCl, pH 6.8, 2%, w/v, SDS, 10% glycerol and 40 mM dithiothreitol) and proteins were then analysed under denaturing conditions. The stoichiometry of the STxB-B23 and STxBBiP interactions were quantified as given in the Supplementary Table S1 . In macrophages, the Triton X-100-insoluble (nuclear) fraction was solubilized in RIPA buffer (Mallard et al., 2002) and analysed after anti-STxB immunoprecipitation, as described above for the cytoplasmic fraction.
Protein sequencing
For protein sequencing, several immunoprecipitation reactions were performed in parallel, and the resulting proteins were pooled and cut from an Amido Black stained gel. Protein sequencing of internal peptides was performed on an Applied Biosystems 473A Sequencer after enzymatic digestion with trypsin and separation of the resulting protein fragments was performed by HPLC. For each protein, three peptides were sequenced and the resulting sequences were found to be 100% identical with the indicated proteins.
